US Stock MarketDetailed Quotes

XTNT Xtant Medical

Watchlist
  • 0.4674
  • -0.0376-7.45%
Close Jan 8 16:00 ET
  • 0.5096
  • +0.0422+9.03%
Post 20:01 ET
64.97MMarket Cap-3.60P/E (TTM)

Xtant Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
11.66%27.94M
48.00%29.94M
55.34%27.87M
57.50%91.3M
84.07%28.11M
73.00%25.02M
32.43%20.23M
38.46%17.94M
4.90%57.97M
9.31%15.27M
Operating revenue
11.66%27.94M
48.00%29.94M
55.34%27.87M
57.50%91.3M
84.07%28.11M
73.00%25.02M
32.43%20.23M
38.56%17.94M
5.12%57.97M
9.44%15.27M
Cost of revenue
20.08%11.63M
46.16%11.36M
42.72%10.57M
38.73%35.84M
57.54%10.97M
47.50%9.69M
12.60%7.77M
37.19%7.41M
13.43%25.83M
10.98%6.96M
Gross profit
6.35%16.31M
49.15%18.58M
64.22%17.3M
72.60%55.47M
106.32%17.14M
94.20%15.33M
48.78%12.46M
39.37%10.54M
-1.09%32.14M
7.94%8.31M
Operating expense
7.29%20.08M
55.44%21.53M
71.50%20.77M
68.74%65.63M
108.80%20.94M
91.09%18.72M
43.17%13.85M
28.97%12.11M
7.01%38.89M
4.41%10.03M
Selling and administrative expenses
6.33%19.38M
52.83%20.89M
69.58%20.25M
69.28%64.29M
108.73%20.45M
90.54%18.23M
44.92%13.67M
30.07%11.94M
7.06%37.98M
3.63%9.8M
-Selling and marketing expense
7.26%11.89M
51.20%13.18M
76.64%12.46M
70.73%38.44M
98.63%11.58M
89.88%11.09M
54.65%8.72M
35.42%7.05M
7.09%22.52M
9.77%5.83M
-General and administrative expense
4.89%7.49M
55.69%7.71M
59.40%7.79M
67.18%25.85M
123.58%8.87M
91.58%7.14M
30.47%4.95M
23.05%4.88M
7.01%15.46M
-4.25%3.97M
Research and development costs
43.06%701K
253.33%636K
202.87%527K
46.01%1.34M
112.07%492K
113.97%490K
-25.31%180K
-18.31%174K
5.17%915K
53.64%232K
Operating profit
-11.58%-3.78M
-111.79%-2.95M
-120.18%-3.47M
-50.38%-10.16M
-120.77%-3.81M
-78.16%-3.39M
-7.00%-1.39M
13.93%-1.58M
-75.27%-6.76M
9.79%-1.72M
Net non-operating interest income expense
-68.40%-1.2M
-26.21%-992K
-70.76%-835K
-67.91%-2.79M
-72.84%-802K
-61.82%-712K
-97.98%-786K
-36.21%-489K
-66.93%-1.66M
0.43%-464K
Non-operating interest income
--0
--0
--0
380.65%149K
-48.39%16K
--48K
--0
--86K
--31K
--31K
Non-operating interest expense
57.76%1.2M
26.21%992K
45.22%835K
73.64%2.94M
65.25%818K
72.73%760K
97.98%786K
60.17%575K
70.05%1.69M
6.22%495K
Other net income (expense)
-99.87%14K
113K
-27K
11.91M
882K
11.03M
Gain on sale of security
--27K
--118K
---39K
--265K
----
----
----
----
----
----
Special income (charges)
--0
----
----
--11.69M
--666K
--11.03M
----
----
--0
--0
-Less：Restructuring and merger&acquisition
--0
----
----
---11.69M
---666K
---11.03M
----
----
--0
--0
Other non- operating income (expenses)
---13K
---5K
--12K
---49K
----
----
----
----
----
----
Income before tax
-171.59%-4.96M
-75.70%-3.83M
-109.78%-4.33M
87.68%-1.04M
-70.29%-3.73M
396.20%6.93M
-28.29%-2.18M
5.71%-2.07M
-73.56%-8.42M
7.95%-2.19M
Income tax
102.70%62K
176.92%36K
423.08%68K
-2,559.42%-1.7M
2,647.62%577K
-17,792.31%-2.3M
0.00%13K
-43.48%13K
69K
122.34%21K
Net income
-154.43%-5.02M
-76.30%-3.86M
-111.74%-4.4M
107.78%660K
-94.79%-4.3M
492.31%9.23M
-28.07%-2.19M
6.10%-2.08M
-74.98%-8.49M
3.24%-2.21M
Net income continuous Operations
-154.43%-5.02M
-76.30%-3.86M
-111.74%-4.4M
107.78%660K
-94.79%-4.3M
492.31%9.23M
-28.07%-2.19M
6.10%-2.08M
-74.98%-8.49M
3.24%-2.21M
Minority interest income
Net income attributable to the parent company
-154.43%-5.02M
-76.30%-3.86M
-111.74%-4.4M
107.78%660K
-94.79%-4.3M
492.31%9.23M
-28.07%-2.19M
6.10%-2.08M
-74.98%-8.49M
3.24%-2.21M
Preferred stock dividends
Other preferred stock dividends
-113.38%-1.01M
-471K
Net income attributable to common stockholders
-154.43%-5.02M
-76.30%-3.86M
-111.26%-3.4M
107.78%660K
-94.79%-4.3M
492.31%9.23M
-28.07%-2.19M
27.38%-1.61M
-74.98%-8.49M
3.24%-2.21M
Basic earnings per share
-157.14%-0.04
-50.00%-0.03
-50.00%-0.03
111.11%0.01
-50.00%-0.03
333.33%0.07
0.00%-0.02
33.33%-0.02
-50.00%-0.09
33.33%-0.02
Diluted earnings per share
-157.14%-0.04
-50.00%-0.03
-50.00%-0.03
111.11%0.01
-50.00%-0.03
333.33%0.07
0.00%-0.02
33.33%-0.02
-50.00%-0.09
33.33%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 11.66%27.94M48.00%29.94M55.34%27.87M57.50%91.3M84.07%28.11M73.00%25.02M32.43%20.23M38.46%17.94M4.90%57.97M9.31%15.27M
Operating revenue 11.66%27.94M48.00%29.94M55.34%27.87M57.50%91.3M84.07%28.11M73.00%25.02M32.43%20.23M38.56%17.94M5.12%57.97M9.44%15.27M
Cost of revenue 20.08%11.63M46.16%11.36M42.72%10.57M38.73%35.84M57.54%10.97M47.50%9.69M12.60%7.77M37.19%7.41M13.43%25.83M10.98%6.96M
Gross profit 6.35%16.31M49.15%18.58M64.22%17.3M72.60%55.47M106.32%17.14M94.20%15.33M48.78%12.46M39.37%10.54M-1.09%32.14M7.94%8.31M
Operating expense 7.29%20.08M55.44%21.53M71.50%20.77M68.74%65.63M108.80%20.94M91.09%18.72M43.17%13.85M28.97%12.11M7.01%38.89M4.41%10.03M
Selling and administrative expenses 6.33%19.38M52.83%20.89M69.58%20.25M69.28%64.29M108.73%20.45M90.54%18.23M44.92%13.67M30.07%11.94M7.06%37.98M3.63%9.8M
-Selling and marketing expense 7.26%11.89M51.20%13.18M76.64%12.46M70.73%38.44M98.63%11.58M89.88%11.09M54.65%8.72M35.42%7.05M7.09%22.52M9.77%5.83M
-General and administrative expense 4.89%7.49M55.69%7.71M59.40%7.79M67.18%25.85M123.58%8.87M91.58%7.14M30.47%4.95M23.05%4.88M7.01%15.46M-4.25%3.97M
Research and development costs 43.06%701K253.33%636K202.87%527K46.01%1.34M112.07%492K113.97%490K-25.31%180K-18.31%174K5.17%915K53.64%232K
Operating profit -11.58%-3.78M-111.79%-2.95M-120.18%-3.47M-50.38%-10.16M-120.77%-3.81M-78.16%-3.39M-7.00%-1.39M13.93%-1.58M-75.27%-6.76M9.79%-1.72M
Net non-operating interest income expense -68.40%-1.2M-26.21%-992K-70.76%-835K-67.91%-2.79M-72.84%-802K-61.82%-712K-97.98%-786K-36.21%-489K-66.93%-1.66M0.43%-464K
Non-operating interest income --0--0--0380.65%149K-48.39%16K--48K--0--86K--31K--31K
Non-operating interest expense 57.76%1.2M26.21%992K45.22%835K73.64%2.94M65.25%818K72.73%760K97.98%786K60.17%575K70.05%1.69M6.22%495K
Other net income (expense) -99.87%14K113K-27K11.91M882K11.03M
Gain on sale of security --27K--118K---39K--265K------------------------
Special income (charges) --0----------11.69M--666K--11.03M----------0--0
-Less：Restructuring and merger&acquisition --0-----------11.69M---666K---11.03M----------0--0
Other non- operating income (expenses) ---13K---5K--12K---49K------------------------
Income before tax -171.59%-4.96M-75.70%-3.83M-109.78%-4.33M87.68%-1.04M-70.29%-3.73M396.20%6.93M-28.29%-2.18M5.71%-2.07M-73.56%-8.42M7.95%-2.19M
Income tax 102.70%62K176.92%36K423.08%68K-2,559.42%-1.7M2,647.62%577K-17,792.31%-2.3M0.00%13K-43.48%13K69K122.34%21K
Net income -154.43%-5.02M-76.30%-3.86M-111.74%-4.4M107.78%660K-94.79%-4.3M492.31%9.23M-28.07%-2.19M6.10%-2.08M-74.98%-8.49M3.24%-2.21M
Net income continuous Operations -154.43%-5.02M-76.30%-3.86M-111.74%-4.4M107.78%660K-94.79%-4.3M492.31%9.23M-28.07%-2.19M6.10%-2.08M-74.98%-8.49M3.24%-2.21M
Minority interest income
Net income attributable to the parent company -154.43%-5.02M-76.30%-3.86M-111.74%-4.4M107.78%660K-94.79%-4.3M492.31%9.23M-28.07%-2.19M6.10%-2.08M-74.98%-8.49M3.24%-2.21M
Preferred stock dividends
Other preferred stock dividends -113.38%-1.01M-471K
Net income attributable to common stockholders -154.43%-5.02M-76.30%-3.86M-111.26%-3.4M107.78%660K-94.79%-4.3M492.31%9.23M-28.07%-2.19M27.38%-1.61M-74.98%-8.49M3.24%-2.21M
Basic earnings per share -157.14%-0.04-50.00%-0.03-50.00%-0.03111.11%0.01-50.00%-0.03333.33%0.070.00%-0.0233.33%-0.02-50.00%-0.0933.33%-0.02
Diluted earnings per share -157.14%-0.04-50.00%-0.03-50.00%-0.03111.11%0.01-50.00%-0.03333.33%0.070.00%-0.0233.33%-0.02-50.00%-0.0933.33%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Collegium Pharmaceutical
COLL
+14.41%
eBay
EBAY
+9.86%
Halozyme Therapeutics
HALO
+5.02%
SilverCrest Metals
SILV
+4.63%
Workday
WDAY
+2.01%

Unlock the Full List